Clinical Trial Update: Study to Evaluate Safety and Efficacy of LifeLiver in Acute or Acute-on-Chronic Liver Failure Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of LifeLiver in acute liver failure and acute-on-chronic liver failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure
• On Chronic Liver Failure

Drugs mentioned

• LifeLiver

Snippet

Sponsor: HLB Cell Co., Ltd. | Conditions: Acute Liver Failure, Acute-On-Chronic Liver Failure | Phase 2 | Status: UNKNOWN